Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Harvard Bioscience (Nasdaq: HBIO) will release its financial results for the quarter ended June 30, 2026 before the market opens on August 11, 2026.

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) will release its financial results for the quarter ended June 30, 2026 before the market opens on August 11, 2026. The company will host an earnings conference call at 8:00 a.m. Eastern Time the same day to discuss the results.

Analysts who wish to ask questions must register in advance to receive dial-in details and a unique PIN. Other participants can access an audio-only webcast via the events and presentations section of the investor website. The earnings release, financial information and slide presentation will be available in the Investor Relations section of Harvard Bioscience’s website.

Argus Jul 28 session

-1.17% close to close Open Argus

Details

News Market Reaction – HBIO

In the Jul 28 session, HBIO declined 1.17%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

An effective S-3 resale registration covered securities sold by selling securityholders rather than ...

Analysis

An effective S-3 resale registration covered securities sold by selling securityholders rather than by the company. The platform record adds a potential resale overhang to this scheduling notice; the low short-positioning level was another relevant risk context.

Key Figures

Quarter end: June 30, 2026 Results announcement date: August 11, 2026 Conference call time: 8:00 a.m. ET

Quarter end

June 30, 2026

Second quarter 2026

Results announcement date

August 11, 2026

Before the market opens

Conference call time

8:00 a.m. ET

August 11, 2026

Historical Context

5 past events · Latest: May 12

5 events

1. May 12

   Q1 earnings results

   24h Move

   -20.9%

   Revenue declined despite improved gross margin and a sharply narrower net loss.

2. May 07

   Investor conference participation

   24h Move

   -6.2%

   Management announced participation in two virtual investor events during May.

3. Apr 28

   Q1 earnings scheduling

   24h Move

   -5.6%

   The company scheduled its first-quarter results release and conference call.

4. Mar 12

   FY25 earnings results

   24h Move

   -2.6%

   Full-year results included guidance, margin metrics, and a substantial goodwill impairment.

5. Mar 06

   Reverse stock split

   24h Move

   -11.6%

   The company announced a one-for-ten reverse stock split effective March 13.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HOLLISTON, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Analysts who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Company Contact:
Mark Frost
Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Harvard Bioscience (HBIO) Q2 2026 earnings conference call scheduled?

Harvard Bioscience will hold its Q2 2026 earnings conference call on August 11, 2026 at 8:00 a.m. Eastern Time. According to Harvard Bioscience, financial results for the quarter ended June 30, 2026 will be released before the market opens that day.

How can analysts join the Harvard Bioscience (HBIO) Q2 2026 earnings call and ask questions?

Analysts must register in advance to join the Harvard Bioscience Q2 2026 earnings call and ask questions. According to Harvard Bioscience, registration provides the necessary dial-in numbers and a unique PIN required to access the analyst Q&A portion of the call.

How can investors listen to the Harvard Bioscience (HBIO) Q2 2026 earnings webcast?

Investors can listen to an audio-only webcast of the Harvard Bioscience Q2 2026 earnings call via the events and presentations section of the company’s investor website. According to Harvard Bioscience, this online webcast is available for participants who do not need phone access.

Where will Harvard Bioscience (HBIO) post Q2 2026 earnings materials for investors?

Harvard Bioscience will provide the Q2 2026 earnings release, related financial information and a slide presentation in the Investor Relations section of its website. According to Harvard Bioscience, these materials will be available in connection with the August 11, 2026 conference call.

What period will Harvard Bioscience (HBIO) report in its Q2 2026 earnings announcement?

Harvard Bioscience will report financial results for the quarter ended June 30, 2026 in its Q2 2026 announcement. According to Harvard Bioscience, these results will be released before the market opens on August 11, 2026, followed by a conference call.

Who is the investor relations contact for Harvard Bioscience (HBIO) regarding Q2 2026 results?

The investor relations contact is Mark Frost, Chief Financial Officer of Harvard Bioscience. According to Harvard Bioscience, he can be reached at (508) 893-3120 or via email at investors@harvardbioscience.com for questions about the Q2 2026 earnings call.